FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in AustraliaLikeFollowShareClick here to read full articlehttps://www.contagionlive.com/view/fda-clears-immuron-s-imm-529-for-clinica...Share your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk Immuron a question about this update.DiscoverShare your feedbackDiscover
